SEK 3.06
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 36.98 Million SEK | -16.77% |
2022 | 44.43 Million SEK | -3.89% |
2021 | 46.23 Million SEK | 19.16% |
2020 | 38.8 Million SEK | 3.16% |
2019 | 37.61 Million SEK | 293.43% |
2018 | 9.56 Million SEK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 33.92 Million SEK | -5.2% |
2024 Q1 | 35.78 Million SEK | -3.25% |
2024 Q3 | 30.24 Million SEK | -10.83% |
2023 Q3 | 36.05 Million SEK | -9.18% |
2023 FY | 36.98 Million SEK | -16.77% |
2023 Q1 | 38.79 Million SEK | -12.7% |
2023 Q4 | 36.98 Million SEK | 2.59% |
2023 Q2 | 39.69 Million SEK | 2.31% |
2022 Q3 | 37.72 Million SEK | -9.87% |
2022 FY | 44.43 Million SEK | -3.89% |
2022 Q2 | 41.85 Million SEK | -9.44% |
2022 Q1 | 46.21 Million SEK | -0.05% |
2022 Q4 | 44.43 Million SEK | 17.8% |
2021 Q1 | - SEK | -100.0% |
2021 FY | 46.23 Million SEK | 19.16% |
2021 Q4 | 46.23 Million SEK | 10.68% |
2021 Q3 | 41.77 Million SEK | -15.87% |
2021 Q2 | 49.65 Million SEK | 0.0% |
2020 FY | 38.8 Million SEK | 3.16% |
2020 Q4 | 38.8 Million SEK | 3.38% |
2020 Q3 | 37.53 Million SEK | 0.0% |
2020 Q1 | - SEK | 0.0% |
2019 FY | 37.61 Million SEK | 293.43% |
2018 FY | 9.56 Million SEK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aino Health AB (publ) | 14.36 Million SEK | -157.473% |
Bonzun AB (publ) | 6.95 Million SEK | -432.173% |
Kontigo Care AB (publ) | 19.05 Million SEK | -94.132% |
RaySearch Laboratories AB (publ) | 1.21 Billion SEK | 96.962% |
Surgical Science Sweden AB (publ) | 357.46 Million SEK | 89.653% |